| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | carbon-sulfur lyase activity | 7.14e-06 | 16 | 48 | 3 | GO:0016846 | |
| GeneOntologyMolecularFunction | zinc ion binding | 2.35e-04 | 891 | 48 | 9 | GO:0008270 | |
| GeneOntologyMolecularFunction | estrogen response element binding | 3.07e-04 | 11 | 48 | 2 | GO:0034056 | |
| Domain | Oest_rcpt/oest-rel_rcp | 5.91e-05 | 5 | 46 | 2 | IPR024178 | |
| Domain | C345C | 7.88e-04 | 17 | 46 | 2 | SM00643 | |
| Domain | ZZ | 8.85e-04 | 18 | 46 | 2 | PF00569 | |
| Domain | ZF_ZZ_2 | 8.85e-04 | 18 | 46 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 8.85e-04 | 18 | 46 | 2 | PS01357 | |
| Domain | Znf_ZZ | 9.88e-04 | 19 | 46 | 2 | IPR000433 | |
| Domain | NTR | 9.88e-04 | 19 | 46 | 2 | PF01759 | |
| Domain | ZnF_ZZ | 9.88e-04 | 19 | 46 | 2 | SM00291 | |
| Domain | Netrin_module_non-TIMP | 9.88e-04 | 19 | 46 | 2 | IPR018933 | |
| Domain | EPHD | 1.33e-03 | 22 | 46 | 2 | PS51805 | |
| Domain | NTR | 1.45e-03 | 23 | 46 | 2 | PS50189 | |
| Domain | Netrin_domain | 1.45e-03 | 23 | 46 | 2 | IPR001134 | |
| Domain | TIMP-like_OB-fold | 1.86e-03 | 26 | 46 | 2 | IPR008993 | |
| Domain | Znf_RING/FYVE/PHD | 5.25e-03 | 459 | 46 | 5 | IPR013083 | |
| Domain | Znf_FYVE_PHD | 5.66e-03 | 147 | 46 | 3 | IPR011011 | |
| Domain | zf-C4 | 5.73e-03 | 46 | 46 | 2 | PF00105 | |
| Domain | Znf_hrmn_rcpt | 5.73e-03 | 46 | 46 | 2 | IPR001628 | |
| Domain | Nuclear_hrmn_rcpt | 5.73e-03 | 46 | 46 | 2 | IPR001723 | |
| Domain | NUCLEAR_REC_DBD_2 | 5.73e-03 | 46 | 46 | 2 | PS51030 | |
| Domain | NUCLEAR_REC_DBD_1 | 5.73e-03 | 46 | 46 | 2 | PS00031 | |
| Domain | ZnF_C4 | 5.73e-03 | 46 | 46 | 2 | SM00399 | |
| Domain | - | 5.98e-03 | 47 | 46 | 2 | 1.10.565.10 | |
| Domain | HOLI | 6.23e-03 | 48 | 46 | 2 | SM00430 | |
| Domain | Nucl_hrmn_rcpt_lig-bd | 6.23e-03 | 48 | 46 | 2 | IPR000536 | |
| Domain | Hormone_recep | 6.23e-03 | 48 | 46 | 2 | PF00104 | |
| Pubmed | Improving GENCODE reference gene annotation using a high-stringency proteogenomics workflow. | 5.24e-08 | 6 | 49 | 3 | 27250503 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 38411359 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 22988120 | ||
| Pubmed | Overexpression, purification, and crystal structure of native ER alpha LBD. | 1.94e-06 | 2 | 49 | 2 | 11437591 | |
| Pubmed | Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. | 1.94e-06 | 2 | 49 | 2 | 11070086 | |
| Pubmed | Human MLL/KMT2A gene exhibits a second breakpoint cluster region for recurrent MLL-USP2 fusions. | 1.94e-06 | 2 | 49 | 2 | 30899083 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 26639757 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 17631492 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 25643697 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 12351685 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 30977157 | ||
| Pubmed | Expression of the estrogen-related receptor 1 (ERR-1) orphan receptor during mouse development. | 5.83e-06 | 3 | 49 | 2 | 9256346 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 18174157 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 11165056 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 9058380 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 25307539 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 26271712 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 23403054 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 19491275 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 18441008 | ||
| Pubmed | Nuclear insulin receptor substrate 1 interacts with estrogen receptor alpha at ERE promoters. | 5.83e-06 | 3 | 49 | 2 | 15318176 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 9395481 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 23678541 | ||
| Pubmed | Identification of proteins highly expressed in uterine fluid from mice with hydrometra. | 1.16e-05 | 4 | 49 | 2 | 26393907 | |
| Pubmed | Akt/PTEN signaling mediates estrogen-dependent proliferation of primordial germ cells in vitro. | 1.16e-05 | 4 | 49 | 2 | 14525951 | |
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 18509053 | ||
| Pubmed | Ligand-dependent transcription of estrogen receptor alpha is mediated by the ubiquitin ligase EFP. | 1.94e-05 | 5 | 49 | 2 | 17418098 | |
| Pubmed | 2.91e-05 | 6 | 49 | 2 | 12522104 | ||
| Pubmed | 2.91e-05 | 6 | 49 | 2 | 16439465 | ||
| Pubmed | PNRC2 is a 16 kDa coactivator that interacts with nuclear receptors through an SH3-binding motif. | 2.91e-05 | 6 | 49 | 2 | 11574675 | |
| Pubmed | 4.07e-05 | 7 | 49 | 2 | 21445275 | ||
| Pubmed | 6.96e-05 | 9 | 49 | 2 | 23110726 | ||
| Pubmed | Sex-hormone-driven innate antibodies protect females and infants against EPEC infection. | 8.69e-05 | 10 | 49 | 2 | 30250184 | |
| Pubmed | Celastrol recruits UBE3A to recognize and degrade the DNA binding domain of steroid receptors. | 8.69e-05 | 10 | 49 | 2 | 36109631 | |
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 9.18e-05 | 167 | 49 | 4 | 20362541 | |
| Pubmed | 2.02e-04 | 15 | 49 | 2 | 14701856 | ||
| Pubmed | 2.48e-04 | 86 | 49 | 3 | 37253089 | ||
| Pubmed | A strategy for modulation of enzymes in the ubiquitin system. | 2.61e-04 | 17 | 49 | 2 | 23287719 | |
| Pubmed | Broad histone H3K4me3 domains in mouse oocytes modulate maternal-to-zygotic transition. | 4.01e-04 | 21 | 49 | 2 | 27626377 | |
| Pubmed | 4.41e-04 | 22 | 49 | 2 | 23975195 | ||
| Pubmed | 4.83e-04 | 23 | 49 | 2 | 24349082 | ||
| Pubmed | 5.26e-04 | 24 | 49 | 2 | 34215813 | ||
| Pubmed | 5.71e-04 | 25 | 49 | 2 | 35383354 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 7.38e-04 | 774 | 49 | 6 | 15302935 | |
| Pubmed | Forkhead box a2 (FOXA2) is essential for uterine function and fertility. | 9.98e-04 | 33 | 49 | 2 | 28049832 | |
| Pubmed | Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM. | 9.98e-04 | 33 | 49 | 2 | 26864203 | |
| Pubmed | 1.06e-03 | 34 | 49 | 2 | 32553152 | ||
| Pubmed | 1.18e-03 | 147 | 49 | 3 | 29576527 | ||
| Pubmed | A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. | 1.22e-03 | 331 | 49 | 4 | 19490893 | |
| Cytoband | Xp11.22 | 2.73e-05 | 54 | 49 | 3 | Xp11.22 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 4.85e-04 | 18 | 33 | 2 | 91 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-06 | 187 | 49 | 5 | 90a1078b0303799fba5d2ca4fa12076fd75b78b1 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-06 | 187 | 49 | 5 | 0f90bce2087aecfdbb377e6f46c6e468efbb6e28 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-06 | 187 | 49 | 5 | 76c957b2976d38adb45e07bcf96c689442e1fc20 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.41e-05 | 167 | 49 | 4 | d50311b1f66f143bae4c4cf50e2e9b13c85d6920 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.41e-05 | 167 | 49 | 4 | 7abc785e688a384672d7fb5a62d32538fe7e5a51 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.00e-05 | 174 | 49 | 4 | 1d157f7a919c8246e83d8060d2a0017c6c781ef3 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.18e-05 | 176 | 49 | 4 | 8e7f38de8bf68077e2138f4d06c1f55b0fd096cc | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.18e-05 | 176 | 49 | 4 | ed575330a08a6748ea4b28433292c8cfd157d444 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.27e-05 | 177 | 49 | 4 | 7af1a19692f7fe8f691178a4e57d62bc379e3d56 | |
| ToppCell | Mesenchymal_cells-Stromal_fibro.|Mesenchymal_cells / Lineage and Cell class | 4.66e-05 | 181 | 49 | 4 | f8d914fdc06aaa75a4dc9158daf574ca28fa5432 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.07e-05 | 185 | 49 | 4 | d5f5866924648a3c14e2596218fd548a31777aa3 | |
| ToppCell | droplet-Kidney-nan-3m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.63e-05 | 190 | 49 | 4 | f61e21d53f2f7804ac6e40ab6c7f69838aa94d6a | |
| ToppCell | droplet-Kidney-nan-3m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.63e-05 | 190 | 49 | 4 | 2abeb013bb83c578e67dcb985ba44ca63134950b | |
| ToppCell | droplet-Kidney-nan-3m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.74e-05 | 191 | 49 | 4 | d1205aab0937f2becfcd239610e9b78fb8a0c886 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-05 | 192 | 49 | 4 | 853a930e0641ffb50cbb4cef5837c70d75c3fc39 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-05 | 192 | 49 | 4 | d2c03490c5e835d0f0a732803093c64b8d4b4029 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.86e-05 | 192 | 49 | 4 | cdc652dbfabe41b324fd85c1ed933d29fb73a49f | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.86e-05 | 192 | 49 | 4 | 29bee88b45e23f16543ffc7cc361bc5da5d16a2b | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-05 | 192 | 49 | 4 | 49281626ecad0456fdbded2378b7028d7b589686 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.98e-05 | 193 | 49 | 4 | ebd090d7801480b3cee45caac3d30cc991836769 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.98e-05 | 193 | 49 | 4 | 22c58032e58730715224d7934968ce92d150b0e8 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.98e-05 | 193 | 49 | 4 | 573ad2f848bede1fe20c7b4b352a9242ec294725 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.10e-05 | 194 | 49 | 4 | c49f72441b3557e2c3a9c4239e68c0cf0652814b | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.10e-05 | 194 | 49 | 4 | 35b30bc954750e939f81a9a7498b8bc2ce69a299 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-E|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.47e-05 | 197 | 49 | 4 | 9b1c1d72c5a8c90d71ae31e4c198d2276872eaa0 | |
| ToppCell | Tracheal-NucSeq-Stromal-Mesofibroblastic-Mesothelia|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.47e-05 | 197 | 49 | 4 | e91572edbe48d40269ee2cf7c858764cff6985ac | |
| ToppCell | Tracheal-NucSeq-Stromal-Mesofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.47e-05 | 197 | 49 | 4 | 7e3f78a61089d1200cc6b0fa2034bf2998651694 | |
| ToppCell | droplet-Bladder-nan-24m-Epithelial-bladder_mesenchymal_cell_(Scara5+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.60e-05 | 198 | 49 | 4 | d4f74320ea6c1a7e568ee5bc48bb66cb45e1004d | |
| ToppCell | 367C-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 6.73e-05 | 199 | 49 | 4 | 2aed8f4a225a3762a5e7ce99aacad9b2a37d61f1 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 6.73e-05 | 199 | 49 | 4 | c40ca26345753a2197bd9389d7323f7491c1e11d | |
| ToppCell | 367C-Fibroblasts-Fibroblast-E-|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.86e-05 | 200 | 49 | 4 | 57b9d6aa2265ab178a5886f36ecc66115bd382a8 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_adventitial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.86e-05 | 200 | 49 | 4 | fc3c4778841c4b8bac0afb458352614b2c460617 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.86e-05 | 200 | 49 | 4 | 36de49593cf6ff1c9229fcceb150c1d68658a360 | |
| ToppCell | (5)_Fibroblast-E|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.86e-05 | 200 | 49 | 4 | 75e5ecb05e965e24d569aa2ef5cdf740b1528c06 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-E|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.86e-05 | 200 | 49 | 4 | ddfbc004e7bd2fd3f11f046ed8fc049277160547 | |
| ToppCell | distal-1-mesenchymal-Adventitial_Fibroblast|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.86e-05 | 200 | 49 | 4 | 738060ed65fa5473fdb39e686f7cdecc059ed92c | |
| ToppCell | Parenchymal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.86e-05 | 200 | 49 | 4 | 4c3c11dd5e71ebc3d62264eeaeb71a850b149779 | |
| ToppCell | TCGA-Head_and_Esophagus-Metastatic|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 1.82e-04 | 100 | 49 | 3 | 74d66f84ff546f4b7354f14a38e5178ee77b5a25 | |
| Drug | 2,2',4,4'-tetrahydroxybenzophenone | 2.95e-06 | 14 | 47 | 3 | ctd:C035476 | |
| Drug | Nalidixic acid sodium salt hydrate; Up 200; 14.6uM; MCF7; HT_HG-U133A | 3.29e-06 | 199 | 47 | 6 | 4691_UP | |
| Drug | benzophenone-2 | 3.69e-06 | 15 | 47 | 3 | CID000008571 | |
| Drug | OH-PCB 30 | 4.53e-06 | 16 | 47 | 3 | CID000105036 | |
| Drug | 7alpha-methyl-17alpha-ethynylestradiol | 1.25e-05 | 3 | 47 | 2 | ctd:C475050 | |
| Drug | 4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene | 2.50e-05 | 4 | 47 | 2 | ctd:C504750 | |
| Drug | ZK 119010 | 2.50e-05 | 4 | 47 | 2 | CID000130936 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 3.61e-05 | 182 | 47 | 5 | 3887_DN | |
| Drug | DY131 | 4.15e-05 | 5 | 47 | 2 | CID000644030 | |
| Drug | XCT790 | 4.15e-05 | 5 | 47 | 2 | CID006918788 | |
| Drug | Carbarsone [121-59-5]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 4.66e-05 | 192 | 47 | 5 | 4110_DN | |
| Drug | Fillalbin [4540-25-4]; Up 200; 13.8uM; PC3; HT_HG-U133A | 4.89e-05 | 194 | 47 | 5 | 4092_UP | |
| Drug | Guanadrel sulfate [22195-34-2]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 5.14e-05 | 196 | 47 | 5 | 4720_UP | |
| Drug | Sulfachloropyridazine [80-32-0]; Up 200; 14uM; PC3; HT_HG-U133A | 5.26e-05 | 197 | 47 | 5 | 3769_UP | |
| Drug | Conessine [546-06-5]; Up 200; 11.2uM; HL60; HT_HG-U133A | 5.26e-05 | 197 | 47 | 5 | 2135_UP | |
| Drug | Ifosfamide [3778-73-2]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 5.26e-05 | 197 | 47 | 5 | 3485_UP | |
| Drug | Methantheline bromide [53-46-3]; Up 200; 9.6uM; HL60; HT_HG-U133A | 5.26e-05 | 197 | 47 | 5 | 6137_UP | |
| Drug | Moxonidine [75438-57-2]; Up 200; 16.6uM; PC3; HT_HG-U133A | 5.65e-05 | 200 | 47 | 5 | 4084_UP | |
| Drug | Quercetine dihydrate [6151-25-3]; Up 200; 11.8uM; PC3; HT_HG-U133A | 5.65e-05 | 200 | 47 | 5 | 4264_UP | |
| Drug | Netilmicin sulfate [56931-57-2]; Up 200; 2.8uM; MCF7; HT_HG-U133A | 5.65e-05 | 200 | 47 | 5 | 6005_UP | |
| Drug | pSAP | 6.22e-05 | 6 | 47 | 2 | CID000007171 | |
| Drug | oxybenzone | 7.15e-05 | 39 | 47 | 3 | CID000004632 | |
| Drug | Demetric acid | 7.72e-05 | 40 | 47 | 3 | CID000025440 | |
| Drug | d-equilenin | 8.32e-05 | 41 | 47 | 3 | CID000010597 | |
| Drug | CI628M | 8.70e-05 | 7 | 47 | 2 | CID003035794 | |
| Drug | 4-hydroxyethynylestradiol | 1.16e-04 | 8 | 47 | 2 | CID000066396 | |
| Drug | 1,3-dibromopropane | 1.16e-04 | 8 | 47 | 2 | CID000008001 | |
| Drug | o,p'-DDT | 1.42e-04 | 49 | 47 | 3 | CID000013089 | |
| Drug | ZNS 114-666 | 1.42e-04 | 49 | 47 | 3 | CID000409441 | |
| Drug | U23,469 | 1.49e-04 | 9 | 47 | 2 | CID000161922 | |
| Drug | OH-PCB 61 | 1.49e-04 | 9 | 47 | 2 | CID000105101 | |
| Drug | p,p'-hydroxy-DDT | 1.51e-04 | 50 | 47 | 3 | CID000076302 | |
| Disease | cryptorchidism (biomarker_via_orthology) | 1.35e-04 | 11 | 47 | 2 | DOID:11383 (biomarker_via_orthology) | |
| Disease | methylcobalamin deficiency type cblE, response to antineoplastic agent | 1.92e-04 | 13 | 47 | 2 | GO_0097327, MONDO_0009354 | |
| Disease | breast carcinoma (is_implicated_in) | 7.28e-04 | 25 | 47 | 2 | DOID:3459 (is_implicated_in) | |
| Disease | macular degeneration (is_implicated_in) | 8.50e-04 | 27 | 47 | 2 | DOID:4448 (is_implicated_in) | |
| Disease | cerebral white matter volume change measurement, age at assessment | 9.14e-04 | 28 | 47 | 2 | EFO_0008007, EFO_0021499 | |
| Disease | prostate cancer (is_marker_for) | 1.98e-03 | 156 | 47 | 3 | DOID:10283 (is_marker_for) | |
| Disease | lung adenocarcinoma, family history of lung cancer | 3.01e-03 | 51 | 47 | 2 | EFO_0000571, EFO_0006953 | |
| Disease | leukemia | 3.49e-03 | 55 | 47 | 2 | C0023418 | |
| Disease | complement factor H-related protein 1 measurement | 3.62e-03 | 56 | 47 | 2 | EFO_0600054 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KLNKLCRDELCRCAE | 1501 | P01024 | |
| DLRVVDCSCRLCRKK | 151 | A0A0U1RR11 | |
| QLNCSELKLKRLCCR | 1701 | Q2TAZ0 | |
| ALRDCKNVLDVSCRK | 336 | Q8NCD3 | |
| KKCRADRRSCSRCDD | 361 | P54762 | |
| ILREDGKTCRRKDVC | 556 | O00339 | |
| VSCSCSRHKLLKRCA | 421 | Q71F56 | |
| CHKQCKDRLSVECRR | 536 | Q7LDG7 | |
| CRCLGDLLDCSRKRL | 51 | Q6UXM1 | |
| IRIRRPCEIKKTDCC | 571 | Q5HYC2 | |
| KNRRKSCQACRLRKC | 231 | P03372 | |
| RIDREKICGRKLECA | 86 | Q9Y5G3 | |
| IFCKKRRKRTAGCCV | 831 | O75164 | |
| CRHTRACIEKLRLCD | 831 | Q5VYJ5 | |
| CECDKRAALCFRRNL | 106 | Q9NZK7 | |
| DLRVVDCSCRLCRKK | 151 | P0DPI3 | |
| CECHKCVLILERRRV | 66 | Q8IXT2 | |
| LLEQDLCRAACVCKR | 171 | Q86XK2 | |
| DLRVVDCSCRLCRKK | 151 | A0A0U1RRI6 | |
| IGRRCVLKDCCKILD | 116 | Q9BTE1 | |
| CRNKCLSVLKTLRDR | 246 | Q9Y586 | |
| ARKRCVYTCKIVECR | 2061 | Q03164 | |
| CEITKRRRKACQACR | 121 | P11474 | |
| RRRKACQACRFTKCL | 126 | P11474 | |
| FLSCICCRRRKRSDD | 546 | Q8IZK6 | |
| TVCEECARRMKKCIR | 851 | Q96AX9 | |
| CCCCRRHRKKPRDKE | 71 | Q8NBV8 | |
| EEKRPKDSSCRTCCR | 961 | Q8N1G1 | |
| KRVCRFCEESRLLLC | 76 | Q6P9F5 | |
| CRNKRIAYKRCITCR | 241 | Q8IWZ5 | |
| KRSRRVRRSKGCDCC | 1721 | Q5UIP0 | |
| DDSECITRLCRKRRC | 56 | Q969E1 | |
| SRKTAKDICKIRCLC | 21 | Q9H156 | |
| SKERLSGKSCACRRC | 61 | Q16842 | |
| ICCACQKTRTSRRAK | 61 | Q13875 | |
| RCCLCKKLLTKETER | 326 | Q6NSI8 | |
| PCEECAEDLRKRLCR | 141 | P55789 | |
| SKDCKELKRCVCERR | 246 | Q8NC01 | |
| RKQSCLKRCITDETC | 81 | Q8IUB2 | |
| CKLICRKCKRHVTDL | 336 | Q96BR9 | |
| LRESLAKCCSCSRKR | 46 | O43511 | |
| RMLKDEVSKCVCRCE | 1136 | P12270 | |
| RRSLGCKRKRECLDE | 191 | A6NKU9 | |
| LDVDCKRLSPDRCKC | 166 | Q6FHJ7 | |
| KRVCDTDRLACSKTC | 476 | Q6UXI7 | |
| CCRCRGRKRCIKKFS | 476 | O75604 | |
| KALCKECVVERCRIL | 551 | Q86UV5 | |
| KRACRCLILDDCEKR | 161 | Q8IYH5 | |
| CSCLVVFRVKICRKE | 576 | Q96RL6 | |
| CCKALCFRRDSAIRK | 1591 | Q5T200 | |
| LCICCCKRQKRTKIR | 976 | Q5VV43 |